The role of the blood transcriptome in innate inflammation and stroke

Abstract  Cerebrovascular disease is a major cause of death and disability, with a poorer outcome in patients having select risk factors including diabetes and hypertension. Risk factors and the state of cerebral ischemia‐reperfusion associated with cerebrovascular occlusion are known to cause inflammatory changes. These events and the inflammatory state are reflected by transcript changes in various components of the blood and can be specifically measured. By defining these changes, new insight into cerebrovascular disease and its therapeutics is being achieved.

[1]  M. Hollstein,et al.  Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke , 2008, Journal of Neurology.

[2]  K. Tan,et al.  Expression Profile of MicroRNAs in Young Stroke Patients , 2009, PloS one.

[3]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[4]  Tao Yang,et al.  An improved version of embolic model of brain ischemic injury in the rat , 2001, Journal of Neuroscience Methods.

[5]  A. García-Méndez,et al.  Proteomic analysis of plasma from patients during an acute coronary syndrome. , 2004, Journal of the American College of Cardiology.

[6]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[7]  V. Menkin.  DIABETES AND INFLAMMATION. , 1941, Science.

[8]  Jialing Huang,et al.  Derepression of MicroRNA-mediated Protein Translation Inhibition by Apolipoprotein B mRNA-editing Enzyme Catalytic Polypeptide-like 3G (APOBEC3G) and Its Family Members* , 2007, Journal of Biological Chemistry.

[9]  Jason Laramie,et al.  Whole blood and leukocyte RNA isolation for gene expression analyses. , 2004, Physiological genomics.

[10]  Silke Szymczak,et al.  Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility , 2010, PloS one.

[11]  T. Murohara,et al.  Platelet-derived 12-hydroxyeicosatetraenoic acid plays an important role in mediating canine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation. , 1998, Circulation.

[12]  V. Ambros,et al.  The regulation of genes and genomes by small RNAs , 2007, Development.

[13]  Y. Suárez,et al.  MicroRNAs as novel regulators of angiogenesis. , 2009, Circulation research.

[14]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[15]  L. Edvinsson,et al.  Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway , 2010, Journal of Neuroinflammation.

[16]  Byron D. Ford,et al.  Expression Analysis Systematic Explorer (EASE) analysis reveals differential gene expression in permanent and transient focal stroke rat models , 2006, Brain Research.

[17]  T. Greiner.  mRNA microarray analysis in lymphoma and leukemia. , 2004, Cancer treatment and research.

[18]  J. Freedman,et al.  Redox State of Dipyridamole is a Critical Determinant for Its Beneficial Antioxidant and Antiinflammatory Effects , 2007, Journal of cardiovascular pharmacology.

[19]  D. Dixon,et al.  Dipyridamole Selectively Inhibits Inflammatory Gene Expression in Platelet–Monocyte Aggregates , 2005, Circulation.

[20]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[21]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[22]  Joseph T. Glessner,et al.  A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene , 2007, Nature.

[23]  D. Hess,et al.  Tactics for Vascular Protection After Acute Ischemic Stroke , 2005, Pharmacotherapy.

[24]  J. Downing,et al.  Gene Expression Profiling of Pediatric Acute Myelogenous Leukemia Materials and Methods , 2022 .

[25]  V. Salomaa,et al.  Diabetes and macrovascular disease. , 1996, Journal of cardiovascular risk.

[26]  M. Yorek.  The Role of Oxidative Stress in Diabetic Vascular and Neural Disease , 2003, Free radical research.

[27]  T. Rana,et al.  Illuminating the silence: understanding the structure and function of small RNAs , 2007, Nature Reviews Molecular Cell Biology.

[28]  S. Carmichael.  Gene expression changes after focal stroke, traumatic brain and spinal cord injuries , 2003, Current opinion in neurology.

[29]  D. Geschwind,et al.  Small Molecule Activation of Adaptive Gene Expression , 2008, Annals of the New York Academy of Sciences.

[30]  J. Freedman,et al.  The Effect of Dipyridamole on Vascular Cell-Derived Reactive Oxygen Species , 2005, Journal of Pharmacology and Experimental Therapeutics.

[31]  David F. Moore,et al.  Using Peripheral Blood Mononuclear Cells to Determine a Gene Expression Profile of Acute Ischemic Stroke: A Pilot Investigation , 2005, Circulation.

[32]  John H. Zhang,et al.  Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury. , 2004, American journal of physiology. Heart and circulatory physiology.

[33]  J. Rotich,et al.  Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke , 2002, Neurology.

[34]  F. Zhan,et al.  The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype. , 2003, Leukemia research.

[35]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[36]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[37]  M. Gladwin,et al.  Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. , 2004, Blood.

[38]  S. Krawetz,et al.  Disease progression and solid tumor survival: a transcriptome decoherence model. , 2010, Molecular and cellular probes.

[39]  Andrew D. Johnson,et al.  Relation of Platelet and Leukocyte Inflammatory Transcripts to Body Mass Index in the Framingham Heart Study , 2010, Circulation.

[40]  M. Souidi,et al.  Statin Induction of Liver Fatty Acid-Binding Protein (L-FABP) Gene Expression Is Peroxisome Proliferator-activated Receptor-α-dependent* , 2004, Journal of Biological Chemistry.

[41]  B. Ford,et al.  Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression , 2005, Neurobiology of Disease.

[42]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[43]  Joseph F. Clark,et al.  Gene Expression in Blood Changes Rapidly in Neutrophils and Monocytes after Ischemic Stroke in Humans: A Microarray Study , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  Hua-Lin Wu,et al.  The effect of statin on the aortic gene expression profiling. , 2007, International journal of cardiology.

[45]  A. Weyrich,et al.  New roles for an old drug: inhibition of gene expression by dipyridamole in platelet-leukocyte aggregates. , 2006, Trends in cardiovascular medicine.

[46]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[47]  J. Gregg,et al.  Gene Expression in Peripheral Blood Differs after Cardioembolic Compared with Large-Vessel Atherosclerotic Stroke: Biomarkers for the Etiology of Ischemic Stroke , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  F. Sharp,et al.  Brain and Blood microRNA Expression Profiling of Ischemic Stroke, Intracerebral Hemorrhage, and Kainate Seizures , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.